Clinical trial
Cross-over, Placebo-controlled, Randomized Trial of β-hydroxybutyrate in Prediabetes
NCT03889210 is registered in ClinicalTrials.gov with University of Auckland, New Zealand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cross-over, Placebo-controlled, Randomized Trial of β-hydroxybutyrate in Prediabetes
- Lead sponsor
- University of Auckland, New Zealand
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2019
- Completion date
- August 30, 2019
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prediabetes